Myocardial re-muscularization can be achieved by implantation of cardiomyocyte-containing grafts. Critical steps towards clinical translation of the 1st generation cardiac re-muscularization therapies include the choice of animal models with high predictive validity for therapeutic outcome in clinical trials.
Keywords: heart failure; myocardium; regeneration; stem cells; tissue engineering.